MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D101. A total of 28 filers reported holding MOLECULIN BIOTECH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $7,000 | +600.0% | 8,979 | +1699.4% | 0.00% | – |
Q3 2019 | $1,000 | -75.0% | 499 | -83.9% | 0.00% | – |
Q1 2017 | $4,000 | – | 3,100 | +1450.0% | 0.00% | – |
Q4 2016 | $0 | -100.0% | 200 | -78.2% | 0.00% | – |
Q3 2016 | $5,000 | -44.4% | 917 | -32.0% | 0.00% | -100.0% |
Q2 2016 | $9,000 | – | 1,349 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Whitegate Investment Counselors, Inc. | 101,781 | $81,000 | 0.01% |
Levy Wealth Management Group, LLC | 14,036 | $11,000 | 0.01% |
WOODMONT INVESTMENT COUNSEL LLC | 12,000 | $10,000 | 0.00% |
Renaissance Technologies | 948,503 | $756,000 | 0.00% |
Qube Research & Technologies Ltd | 132,238 | $105,000 | 0.00% |
Core Wealth Advisors, Inc. | 1,711 | $1,000 | 0.00% |
UBS Group AG | 36,726 | $29,000 | 0.00% |
IFP Advisors, Inc | 0 | $0 | 0.00% |
Squarepoint Ops LLC | 12,342 | $10,000 | 0.00% |
TRUE Private Wealth Advisors | 2,500 | $1,000 | 0.00% |